BTG, a global specialist healthcare company, has received Class III CE Mark certification for DC Bead LUMI, the first commercially
Breaking News
- Brexit – Implications For the Pharma Industry in Ireland The UK’s referendum decision to leave the EU in May 2016 undoubtedly sent shockwaves throughout Europe. European countries are still struggling to interpret what ‘Brexit’ will mean for them. Ireland,...
- EMA to Work With Stakeholders to Improve Product Information For EU Medicines The European Medicines Agency (EMA) has published an action plan to improve the product information (PI) for EU medicines, an information package for patients and healthcare professionals that accompanies every single medicine authorised in...
- Diaceutics Wins at Export Industry Awards Diaceutics, the Irish data insights and solutions company helping patients receive potentially lifesaving medicine through better testing, won the Small & Emerging Exporter of the Year Award at the recent Export...
- Brexit – Key Issues For the Pharmaceutical Industry Brexit – the stark reality is that the UK’s EU membership and the application of all EU legislation in the UK ends automatically at midnight on 30th March 2019! Current understanding...
- European Commission Diagnoses the State of Health in the EU Only by rethinking our health systems can we ensure that they remain fit-for-purpose and provide patient-centred care. This is what the 28 Country Health Profiles recently published by the Commission,...
Allergan plc, a global pharmaceutical company announced topline data from a phase II study with major depressive disorder (MDD). The study
The European Commission has approved Novartis’ Tafinlar (dabrafenib) in combination with Mekinist (trametinib) for the treatment of patients with BRAF
Amryt Pharma, the orphan drug development company that was subject to a reverse takeover of former oil and gas group
Now that the die has been cast, it’s time for the deal-making process to begin – if indeed a deal
Sharp Clinical Services, part of UDG Healthcare plc, has announced a £9 million ($11.2 million) investment to fund a new multiple-phase pharmaceutical
A new project in Wales will enable all NHS Wales Paediatric Diabetes Units to collect patient information in a consistent
Scientists at EPFL and NTU have discovered that combining an anticancer drug with an antirheumatic produces improved effects against tumors.
Scientists from LSTM’s Research Centre for Drugs and Diagnostics (RCDD) have described in a paper published today in Scientific Reports,
The European Medicines Agency (EMA) wants to suspend around 300 marketed generic meds (and applications) coming out of Indian CRO
University of Dundee in the UK has been awarded almost £1m to boost efforts to identify new new antibiotics to
Xeljanz (tofacitinib citrate) receives marketing authorization in the European Union for the treatment of moderate to severe active rheumatoid arthritis
Zika virus (ZIKV), which causes Zika virus disease, is spread to people primarily through the bite of an infected Aedes aegypti or Aedes
Apeiron Biologics has announced that the EMA’s CHMP has recommended the approval of APN311 for immunotherapy of high risk neuroblastoma.
The agency is recommending the suspension of a variety of medications because of unreliable bioequivalence studies conducted by Micro Therapeutic
PureTech will take on the development of two mTORC1 inhibitors from Novartis aimed at stopping the decline of the immune
A new study published in PLOS Medicine’s Special Issue on Dementia has found that the metabolism of omega-3 and
Global healthcare company Sanofi and therapeutic companion software company Voluntis have agreed to a collaboration to help improve decision-making and
Drugmaker Mylan has recalled over 80,000 EpiPens across the world due to reports of the device failing to activate. The
Advertisements
